FDA’s Gottlieb says AI ‘holds enormous promise for the future of medicine’

Michael Walter | | Radiology Business | Artificial Intelligence
scott gottlieb fda

The FDA is working to encourage the use of artificial intelligence (AI) technologies in healthcare, according the prepared remarks by the agency’s commissioner, Scott Gottlieb, MD, at Health Datapalooza in Washington, D.C.

“AI holds enormous promise for the future of medicine,” Gottlieb said in the remarks, as reported by CNBC.  “We're actively developing a new regulatory framework to promote innovation in this space, and support the use of AI-based technologies.”

Gottlieb added that the FDA expects the number of AI-based submissions to continue to rise, “starting with medical imaging devices,” as these technologies evolve.

Click below to read the full story from CNBC.

FDA moves to encourage A.I. in medicine, drug development

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Startup aiming to automate 90% of imaging workflows, creating an ‘AI radiology resident,’ raises $23M
ACR, top health systems form collaborative to help radiologists assess AI solutions
Radiology AI firm Mediaire raises nearly $12.7M in financing
RadNet stock surges 20% to all-time high following news of GE HealthCare partnership
Radiology AI vendor Volpara Health inks $7M Department of Defense contract
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.